Fall T, Holm B, Karlsson A, Ahlgren K M, Kämpe O, von Euler H
Department of Clinical Sciences, Swedish University of Agricultural Sciences (SLU), SE-750 07 Uppsala, Sweden.
Vet Rec. 2008 Aug 30;163(9):266-70. doi: 10.1136/vr.163.9.266.
Fifty-one dogs (27 diabetic dogs, four that had recovered from diabetes and 20 healthy control dogs) were given 0.5 or 1.0 mg glucagon intravenously. Blood samples were taken before the injection and 10 and 20 minutes after it. Samples were analysed to determine C-peptide, insulin and glucose concentrations, and one sample from each dog was analysed for fructosamine. The median (interquartile range) concentrations of C-peptide in the samples taken at 10 minutes were 0.5 (0.3 to 0.8) nmol/l in the control dogs, 0.1 (0 to 0.2) nmol/l in the diabetic dogs, and 0.3 (0.2 to 0.4) nmol/l in the dogs that had recovered from diabetes. Seven of the 51 dogs showed mild adverse reactions after the injection of glucagon.
51只狗(27只糖尿病犬、4只已从糖尿病中康复的犬和20只健康对照犬)静脉注射0.5毫克或1.0毫克胰高血糖素。在注射前以及注射后10分钟和20分钟采集血样。对样本进行分析以测定C肽、胰岛素和葡萄糖浓度,并且对每只狗的一个样本进行果糖胺分析。在10分钟时采集的样本中,对照犬C肽的中位数(四分位间距)浓度为0.5(0.3至0.8)纳摩尔/升,糖尿病犬为0.1(0至0.2)纳摩尔/升,已从糖尿病中康复的犬为0.3(0.2至0.4)纳摩尔/升。51只狗中有7只在注射胰高血糖素后出现轻度不良反应。